Completed projects - old

Aspire

Action and support - Improving the prioritisation and treatment of children with life-threatening illnesses in Malawi

Find out more

Building nursing capacity

Action and support - Improving neurological care for newborns and children in Malawi

Find out more

Community to clinic

Action and support - Strengthening diagnosis, treatment and surveillance in Uganda

Find out more

Where's our vaccine?

Our successful campaign led to the UK’s Department of Health making the MenB vaccine available in the national immunisation programme for infants in the UK.

Find out more about the ‘Where's our vaccine?’ campaign

Broken hearts, broken promises

We campaigned for fairness in the rules used to decide the lifetime value of vaccines, so that the MenB vaccine isn’t only offered to babies. We applied pressure to the UK Government after they broke their promise to look at these unfair rules, delaying their report and stalling progress.

Counting the costs

Our analysis on the lifelong costs of surviving meningitis influenced the UK Government to change its criteria for assessing the value of vaccination.

Read more about Counting the costs

12 Days of Christmas

Action and support - Support our life saving work and help defeat meningitis for good.

Find out more

Meningitis Awareness Week 2019

Advocacy and campaigning - For Meningitis Awareness Week 2019 we're focusing on support for people affected by meningitis

Find out more

Meningitis Awareness Week 2018

Advocacy and campaigning - This year we’re aiming to improve diagnosis of patients with bacterial meningitis and septicaemia with our Safety Netting campaign

Find out more

Meningitis Awareness Week 2017

Advocacy and campaigning - A week of raising awareness and reducing the impact of meningitis and septicaemia. We have one shot to protect students and young adults.

Find out more

Antibody persistence in the population after mass vaccination with a MenA vaccine in Burkina Faso

Research - Investigating how long protection lasts after vaccination by taking blood samples from children and adults and measuring levels of immunity.

Find out more

Assessing the potential benefits of GBS vaccines

Research - Evaluating the potential costs and benefits of introducing a GBS (Group B streptococcal) vaccine in the UK. GBS is the leading cause of bacterial meningitis in newborn babies

Find out more

Could vaccinating teenagers unlock whole population protection against MenB?

Research - A pilot study to inform a national study to find out whether the MenB vaccine appears to prevent teenagers carrying bacteria in the back of the nose and throat.

Find out more

Determining whether Bexsero® can prevent a particular meningococcal strain from causing disease

Research - Developing laboratory tests to monitor how well the MenB vaccine (Bexsero®) is working

Find out more

GBS Genome Library

Group B Streptococcus (GBS) is one of the most common meningitis-causing bacteria in newborns and is a major cause of infant deaths globally. The GBS Genome Library is a vital resource in furthering research in this area, describing the whole genome pathology and epidemiology of GBS for the first time.

Learn more about the GBS Genome Library

How to prioritise decisions about new vaccines - taking public preference into account

Research - Understanding public views and preferences towards different childhood vaccinations

Find out more

Improving understanding of meningococcal disease in Scotland

Research - MRF-supported genome sequencing research backed by Health Protection Scotland to improve the prevention, diagnosis and treatment of meningitis

Find out more

Investigating transmission of GBS to newborn babies in Malawi

Research - Genetic fingerprinting techniques to investigate the relationship between GBS bacteria carried by mothers and those causing severe GBS disease in newborns in Malawi

Find out more

Understanding meningococcal disease: studying patient genomes and their disease causing bacteria

Research - Understanding meningococcal disease by simultaneously studying genetic blueprints of patients and the meningococci causing their illness

Find out more

Understanding the role of ‘peace of mind’ in vaccination

Investigating whether ‘peace of mind’ benefits are a key influence in an individual’s vaccine decision making process

Find out more

Study to evaluate prevention of meningococcal carriage in teenagers (SPIT)

Research - Understanding whether the MenB vaccine has an effect on bacterial carriage in teenagers

Find out more

The projects we work on push forward global awareness and understanding of meningitis and build knowledge on prevention, treatment and support.

What underpins every project we do is whether it will move us closer to our vision of a world free from meningitis.

From research to reports to campaigns, find out more about some of our completed projects.

Completed projects - old

fddf